TW0004105002
TW0004105002
TTY BIOPHARM COMPANY LIMITED
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 20.12B EUR | 18.82B EUR | 18.1B EUR | 20.26B EUR |
Enterprise Value | 20.03B EUR | 17.96B EUR | 16.34B EUR | 18.97B EUR |
Valuation Multiples | ||||
Trailing P/E | 11.62x | 16.33x | 17.56x | 20.7x |
Forward P/E | 10.95x | -- | -- | -- |
Price to Sales | 3.02x | 3.89x | 3.86x | 4.37x |
Price to Book | 2.89x | 2.71x | 2.76x | 2.8x |
EV/Revenue | 3.01x | 3.72x | 3.48x | 4.09x |
EV/EBITDA | 9.73x | 10.39x | 10.37x | 12.53x |
Price to FCF (P/FCF) | 20.7x | 13.03x | 11.98x | 15.12x |
EV/FCF | 20.61x | 12.43x | 10.81x | 14.15x |
FCF Yield | 4.83% | 7.68% | 8.35% | 6.61% |